Brexit has revealed further the rottenness of the British political Establishment, but I am still truly shocked now to see the Government of the United Kingdom negotiating a major international treaty on the acknowledged, discussed and now published basis that it has every intention of breaking that treaty once it is in force. Officially published […]
Starting in 2021, Americans will require permission to visit Europe… technically the 26 borderless countries within Europe’s Schengen area. The process will start out simple enough, taking about ten minutes to complete and costing around $8. The EU estimates it will grant about 95% of the Americans who apply three years of access to the […]
You won’t believe some of the things that are causing “major stress” for young people in America today. According to a brand new survey that was just released, 58 percent of all American Millennials believe that “life is more stressful right now than ever before”. And so what is precisely making life so stressful for […]
FinTech startups usually use bank investments to enter the market, but Toman is different. It has entered the market without any bank investments. In the course of the past 7 months, Toman has obtained a considerable part of the online transactions of taxi fee payments. The very presence of big banks in the FinTech market […]
China’s government fixed-income market constitutes a US $12-trillion opportunity, according to Emil Nguy.
Enjoying a nice night in, red wine, cheese plates, and a great movie. While the lights are at a nice setting, your dimmer switch goes out, what’s next? You’re going to need to know how to replace a dimmer switch. Maybe you’d like to upgrade your dimmer switch. Knowing how to replace it is crucial. […]
Among the most polarizing stocks on Wall Street is one of it’s most famous — Tesla (TSLA). Since the beginning of last year, shares have climbed or dropped at least 10% more than a dozen times, as some in the investment community look at the stock as a can’t-lose, with others thinking there’s no chance the […]
In a report released today, Jason McCarthy from Maxim Group maintained a Buy rating on Moleculin Biotech (MBRX), with a price target of $3. The company’s shares opened today at $1.27. McCarthy commented: “Following last month’s clearance to begin its European clinical trial of WP1220 (STAT3 inhibitor) in the topical treatment of cutaneous T-cell lymphoma […]
In the entire history of the United States, consumers have never been in so much debt. And that would not be a crisis as long as the vast majority of us were regularly making our debt payments, but as you will see below delinquency levels are starting to rise to extremely alarming levels. In fact, […]
The standard joke about high-yield bonds is that they’re not high yield any longer. Let’s replace it with something better.